Anaemia in the critically ill - The optimal haematocrit

Annals of the Academy of Medicine Singapore

Volumn 30, Issue 3, 2001, Pages 293-299

  Tan, I K S ^a   Lim, J M J ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Blood substitutes; Blood transfusion; Erythropoeitin; Haemoglobin; Oxygen delivery

Indexed keywords

BLOOD SUBSTITUTE; CYANOCOBALAMIN; ERYTHROPOIETIN; FLUOROCARBON; FOLIC ACID; HEMOGLOBIN; IRON;

ANEMIA; BLOOD GROUP INCOMPATIBILITY; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN OXYGEN CONSUMPTION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CRITICAL ILLNESS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ERYTHROPOIESIS; GASTROINTESTINAL HEMORRHAGE; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; HYPERBARIC OXYGEN; IMMUNOMODULATION; INFECTION RISK; INTENSIVE CARE; MORTALITY; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; OXYGEN TRANSPORT; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE;

EID: 0034869044     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (65)

1. Von Ahsen N, Muller C, Serke S, Frei U, Eckardt K U. Important role of nondiagnostic blood loss and blunted erythropoeitic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-9.
2. Corwin H L, Parsonnet K C, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest 1995; 108:767-71.
3. Zimmerman J E, Seneff M G, Sun X, Wagner D P, Knaus W A. Evaluating laboratory usage in the intensive care unit: Patient and institutional characteristics that influence the frequency of blood sampling. Crit Care Med 1997; 25:737-48.
4. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J for the Canadian Critical Care Trials Group. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999; 27:2812-7.
5. Jongen-Lavrencic M, Peeters H R, Rozemuller H, Rombuots W J, Martens A C, Vreuqdenhil G, et al. IL-6-induced anaemia in rats: Possible pathogenetic implications for anaemia observed in chronic inflammations. Clin Exp Immunol 1996; 103:328-34.
6. Campillo B, Sittoun J, de Gialluly E. Prophylaxis of folate deficiency in acutely ill patients: results of a randomised clinical trial. Intensive Care Med 1988; 14:640-5.
7. Fortin M C, Amyot S L, Geadah D, Leblanc M. Serum concentrations and clearance of folic acid and pyridoxal-5'phosphate during venovenous continuous renal replacement therapy. Intensive Care Med 1999; 25:594-8.
8. Krafte Jacobs B, Levetown M L, Bray G L, Ruttimann U E, Pollack M M. Erythropoietin response to critical illness. Crit Care Med 1994; 22:821-6.
9. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Merlot C, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23:159-62.
10. Crowell J W, Smith E E. Determinant of the optimal haematocrit. J Appl Physiol 1967; 22:501-4.
11. Kusonoki M, Kimura K, Nakamura M, Isaka Y, Yoneda S, Abe H. Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1981; 1:413-7.
12. Hino A, Ueda S, Mizukawa N, Imahori Y, Tenjin H. Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke 1992; 23:423-6.
13. Catlin D H, Murray B A. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA 1996; 276:231-7.
14. Brien A J, Simon T L. The effects of red blood cell infusion on 10-km race time. JAMA 1987; 257:2761-5.
15. Ingjer F, Myhre K. Physiological effects of altitude training on elite male cross-country skiers. J Sports Sci 1992; 10:37-47.
16. Wilkerson D K, Rosen A L, Sehqal L R, Gould S A. Sehgal H L, Moss G S. Limit of cardiac compensation in anemic baboons. Surgery 1988; 103:665.
17. Weiskopf R B, Viele M K, Feiner J, Kelley S. Leiberman J, Noorani M. et al. Human cardiovascular and metabolic response to acute severe isovolemic anemia. JAMA 1998; 279:217-21.
18. Toy P, Feiner J, Viele M, Watson J, Yeap H, Weiskopf R. Fatigue during acute isovolemic anemia in healthy resting humans. Transfusion 2000: 40:457-60.
19. Weiskopf R B, Kramer J H, Viele M, Neumann M, Feiner J R, Watson J J, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92:1646-52.
20. -1. Anesthesiology 2000; 92:407-13.
21. van Woerkens E C, Trouwborst A, van Lanschot J J. Profound hemodilution: what is the critical level of hemodilution at which oxygen deli very-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75:818-21.
22. Ronco J J, Fenwick J C, Tweeddale M G, Wiggs B R, Phang P T, Cooper D J, et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724-30.
23. -1 with survival. Anaesth Intensive Care 1991; 19:581-3.
24. Viele M K, Weiskopf R B. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34:396-401.
25. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84:732-47.
26. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988; 260:2700-3.
27. Herbert P C, Wells G A, Marshall J C, Tweeddale M, Marshall J, Blajchman M, et al. A Canadian survey of transfusion practices in critically ill patients. Crit Care Med 1998; 26:482-7.
28. Nelson A H, Fleisher L A, Rosenbaum S H. Relationship between postoperative anaemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21:860-6.
29. Carson J L, Duff A, Poses R M, Berlin J A, Spence R K, Trout R, et al. Effect of anemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-60.
30. Ma J Z, Ebben J, Xia H, Collins A J. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10:610-9.
31. Shoemaker W C, Appel P L, Kram H B, Waxman K, Lee T S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94:1176-86.
32. Boyd O, Grounds R M, Bennett E D. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993; 270:2699-707.
33. Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999; 318:1099-103.
34. Ronco J J, Fenwick J C, Tweeddale M G. Does increasing oxygen delivery improve outcome in the critically ill? No. Crit Care Clin 1996; 12:645-59.
35. Friedrich M J. Third millennium challenge: hepatitis C. JAMA 1999; 282:221-2.
36. Blumberg N. Allogenic transfusion and infection: Economic and clinical implications. Semin Hematol 1997; 343(S2):34-40.
37. Vamvakas E C, Carven J H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999; 39:701-10.
38. Carson J L, Altman D G, Duff A, Noveck H, Weinstein M P, Sonnenberg F A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694-700.
39. McAlister F A, Clark H D, Wells P S, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998; 85:171-8.
40. Simchon S, Jan K M, Chien S. Influence of reduced red cell deformability on regional blood flow. Am J Physiol 1987; 253:H898-903.
41. Dietrich K A, Conrad S A, Hebert C A, Levy G L, Romero M D. Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume resuscitated nonsurgical patients. Crit Care Med 1990; 18:940-4.
42. Ronco J J, Phang P T, Walley K R, Wiggs B, Fenwick J C. Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. Am Rev Respir Dis 1991; 143:1267-73.
43. Marik P E, Sibbald W J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-9.
44. Friedlander M H, Simon R, Machiedo G W. The relationship of packed cell transfusion to red blood cell deformability in systemic inflammatory response syndrome. Shock 1998; 9:84-8.
45. Dronen S C, Stern S, Baldursson J, Irvin C, Syverud S. Improved outcome with early blood administration in a near-fatal model of porcine hemorrhagic shock. Am J Emerg Med 1992; 10:533-7.
46. Marshall H P, Capone A, Courcoulas A P, Harbrecht B G, Billiar T R, Udekwu A O, et al. Effects of hemodilution on long-term survival in an uncontrolled hemorrhagic shock model in rats. J Trauma 1997; 43:673-9.
47. Tartter P I, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-6.
48. Purdy F R, Tweeddale M G, Merrick P M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997; 44:1256-61.
49. Hebert P C, Wells G, Blajchman M A, Marshall J, Martin C, Pagialrello G, et al, and the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicenter randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-17.
50. Faris P M, Ritter M A, Abels R I. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996; 78:62-72.
51. Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89:411-8.
52. Goldberg M A, McCutchen J W, Jove M, Di Cerare P, Friedman R J, Oss R, et al. A safety and efficacy comparison study of two dosing regimens of epoetin α in patients undergoing major orthopedic surgery. Am J Orthop 1996; 25:544-52.
53. Corwin H L, Gettinger A, Rodriguez R M, Pearl R G, Bulber D K, Enny C, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-50.
54. Silverberg D S, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves, cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35:1737-44.
55. Jacobs C. Normalization of haemoglobin: why not? Nephrol Dial Transplant 1999; 14(S2):77-9.
56. Besarab A, Bolton W K, Browne J K, Egrie J C, Nissenson A R, Okamoto D M, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584-90.
57. Macdougall I C, Ritz E. The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant 1998; 13:3030-3.
58. Goodnough L T, Brecher M E, Kanter M H, AuBuchon J P, Blood conservation. N Engl J Med 1999; 340:525-33.
59. Vlahakes G J, Lee R, Jacobs E E Jr, LaRaia P J, Austen W G. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100:379-88.
60. Xu L, Sun L, Rollwagen F M, Li Y, Pacheco N D, Pikoulis E, et al. Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 1997; 42:32-41.
61. Spahn D R, van Brempt R, Theilmeier G, Reibold J P, Welte M, Heinzerling H, et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology 1999; 91:1195-208.
62. Conover C, Linberg R, Lejeune L, Gilbert C, Shum K, Shorr R G. Evaluation of the oxygen delivery ability of PEG-hemoglobin in Sprague-Dawley rats during hemodilution. Artif Cells Blood Substit Immobil Biotechnol 1998; 26:199-212.
63. Sloan E P, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory M N, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999; 282:1857-64.
64. Boerema I, Meijne N G, Brummelkamp W K, Bouma S, Mensch M H, Karermans I, et al. Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of blood. J Cardiovasc Surg 1960; 1:113-46.
65. British Committee for Standards in Haematology, Blood Transfusion Task Force, Royal College of Nursing and Royal College of Surgeons in England. The administration of blood and blood components and the management of transfused patients. Transfus Med 1999; 9:227-38.